Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical decision making: from theory to practice. Rationing resources while improving quality. How to get more for less.

× No keyword cloud information.

11 in total

1. Health services research.

Authors: S M Shortell
Journal: Health Serv Res Date: 1998-08 Impact factor: 3.402

2. Rationing: a transatlantic perspective.

Authors: S Purdy
Journal: Br J Gen Pract Date: 1996-09 Impact factor: 5.386

3. Standardization of clinical decision making for the conduct of credible clinical research in complicated medical environments.

Authors: A H Morris; T D East; C J Wallace; M Franklin; L Heerman; T Kinder; M Sailor; D Carlson; R Bradshaw
Journal: Proc AMIA Annu Fall Symp Date: 1996

4. Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.

Authors: John C Woodfield; Andre M Van Rij; Ross A Pettigrew; Antje van der Linden; Donna Bolt
Journal: World J Surg Date: 2005-01 Impact factor: 3.352

5. Approaches to rationing drugs in hospitals. An Australian perspective.

Authors: F Bochner; N G Burgess; E D Martin
Journal: Pharmacoeconomics Date: 1996-11 Impact factor: 4.981

Review 6. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Authors: R Whittington; K L Goa
Journal: Pharmacoeconomics Date: 1995-01 Impact factor: 4.981

7. Risk-sensitive therapeutic strategies for coronary artery disease: toward testing-driven therapy in stable angina patients with low-to-intermediate risk cardiac imaging results.

Authors: D D Miller; B J Gersh
Journal: J Nucl Cardiol Date: 1997 Sep-Oct Impact factor: 5.952

Review 8. Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.

Authors: T van der Weijden; J A Knottnerus; A J Ament; H E Stoffers; R P Grol
Journal: J Epidemiol Community Health Date: 1998-09 Impact factor: 3.710

Review 9. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.

Authors: K L Goa; H Lamb
Journal: Pharmacoeconomics Date: 1997-09 Impact factor: 4.981

10. Costs of novel symptom management interventions and their impact on hospitalizations.

Authors: Charles William Given; Cathy Bradley; Mei You; Alla Sikorskii; Barbara Given
Journal: J Pain Symptom Manage Date: 2010-04 Impact factor: 3.612